F2 and COVID-19: Furthermore, there are findings that suggest that half of the patients hospitalized with COVID-19 become at least transiently positive for aPL antibodies, including anticardiolipin, anti-β2 glycoprotein I, and anti-phosphatidylserine/prothrombin (aPS/PT), which are potentially pathogenic [34].